TherapeuticsMD (NASDAQ:TXMD) reported its Q1 earnings results on Monday, May 16, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
TherapeuticsMD missed estimated earnings by 18.0%, reporting an EPS of $-4.72 versus an estimate of $-4.0.
Revenue was down $533.00 thousand from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.01 which was followed by a 0.0% increase in the share price the next day.
Here's a look at TherapeuticsMD's past performance:
|Quarter||Q4 2021||Q3 2021||Q2 2021||Q1 2021|
To track all earnings releases for TherapeuticsMD visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.